Recent Finacing
Recent Raise
TesoRx Pharma develops and commercializes niche specialty pharmaceuticals, advancing TSX-002—an oral unmodified testosterone enteric‑coated proliposomal formulation—toward Phase 3 while establishing commercial manufacturing and clinical/regulatory leadership.
Focus Areas
Total Raised
Funding round